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The utilization of biomarkers for in vivo and in vitro research is growing rapidly. This is mainly due to the
enormous potential of biomarkers in evaluating molecular and cellular abnormalities in cell models and
in tissue, and evaluating drug responses and the effectiveness of therapeutic intervention strategies.
An important way to analyze the development of the human body is to assess molecular markers in
embryonic specialized cells, which include the ectoderm, mesoderm, and endoderm. Neuronal devel-
opment is controlled through the gene networks in the neural crest and neural tube, both components of
the ectoderm. The neural crest differentiates into several different tissues including, but not limited to,
the peripheral nervous system, enteric nervous system, melanocyte, and the dental pulp. The neural tube
eventually converts to the central nervous system.
This review provides an overview of the differentiation of the ectoderm to a fully functioning nervous
system, focusing on molecular biomarkers that emerge at each stage of the cellular specialization from
multipotent stem cells to completely differentiated cells. Particularly, the otic placode is the origin of
most of the inner ear cell types such as neurons, sensory hair cells, and supporting cells. During the
development, different auditory cell types can be distinguished by the expression of the neurogenin
differentiation factor1 (Neuro D1), Brn3a, and transcription factor GATA3. However, the mature auditory
neurons express other markers including bIII tubulin, the vesicular glutamate transporter (VGLUT1), the
tyrosine receptor kinase B and C (Trk B, C), BDNF, neurotrophin 3 (NT3), Calretinin, etc.
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The nervous system represents the main regulatory network in
the body, providing sensitivity, conductivity, and responsiveness. In
essence, it receives sensory information, conducts this information
through an intricate network, and interprets and responds to the
information by sending motor signals to muscles and glands. The
conductivity is provided by nerve cells where electrochemical
signals are transmitted through long ﬁbers called axons that ﬁnally
release neurotransmitters at the synaptic neuronal junctions
(Biology, 1989).
The nervous system consists of two main parts: the central
nervous system (CNS) and peripheral nervous system (PNS). CNS
includes the brain and spinal cord and PNS includes nerves that
mediate the communication network between the CNS to other
parts of the body. The cell bodies of neurons are gathered in pe-
ripheral ganglions. PNS is also classiﬁed as sympathetic, para-
sympathetic ganglia and enteric nervous system (Frebreg, 2009).
Representing an intricate network the neuronal system ensures a
delicate balance of perception and responsewhere anymalfunction
may lead to severe debilitating diseases. Thus, having a full un-
derstanding of how the nervous system develops will provide
greater possibilities for designing effective intervention strategies
for neurological disorders.
Neural system development is the ﬁrst embryonic system that
begins to form and the last one to be completed after birth. As
illustrated in Fig. 1, the embryological development of the nervous
system entails the formation of three germinal layers or gastrula-
tion. Gastrulation occurs by inward migration of cells from outside
the blastula to the inner part that forms the gastrula. During
gastrulation, the three primary layers (ectoderm, mesoderm, and
endoderm) organize the formation of different tissue and organs
(Purves D, Augustine GJ, Fitzpatrick D, 2001). The ectoderm gives
rise to the nervous system and epidermis. The mesoderm develops
somites, which later differentiate into numerous systems including
but not limited to bone, cartilage, blood vessels, and connective
tissues. The endoderm forms the epithelium of the respiratory
system, digestive systems and also related organs such as the liver
and pancreas. The ectoderm, the outer layer of three germ layers,
consists of three parts: neural crest, neural tube and surface ecto-
derm which ultimately develops into the nervous system, tooth
enamel, epidermis, subcutaneous gland, carotid body to only
mention a few (Henry E Young and Asa C Black, 2014).
As ectoderm differentiation is highly complex a myriad of
different approaches have been used to detect tissue-speciﬁc pro-
tein biomarkers engaged in the various cell signaling processes and
pathways including computational biology (Honardoost et al.,2015), micro-RNA studies (Keshavarzi et al., 2017; Mahmoodian
Sani et al., 2016; Mahmoudian-Sani et al., 2017; Reza and
Ghahfarrokhi, 2017), proteomics (Ahmadinejad et al., 2017;
García-Estrada et al., 2013; Kosalkova et al., 2012), Immunohisto-
chemistry (Ghasemi-Dehkordi et al., 2015), Immunoblotting and
immunoﬂuorescence techniques. Immunohistochemical staining is
widely used in cell and molecular biology to understand the
propagation and localization of protein biomarkers differentially
expressed in different parts of tissue (M.-S. Jami et al., 2014a). It is
accomplished by eliciting speciﬁc antibodies against antigenic
markers where antibodies conjugated to a colorimetric enzyme
causes a color-producing reaction at the antigenic site (Ramos-
Vara, 2005). A more quantitative analytical approach is repre-
sented byWestern blotting which has the ability to identify speciﬁc
proteins from complex protein mixtures obtained from cells
(Mahmood and Yang, 2012). Fluorescence immunoassays are also
frequently used where antibodies containing ﬂuorescent tags
detect speciﬁc antigens within complex protein solutions. All these
techniques generally involve antibody-antigen interactions to
speciﬁcally target biomarkers of clinical or research value. The
utilization of biomarkers for in vivo and in vitro research is growing
rapidly. This is mainly due to the enormous potential of biomarkers
in evaluating molecular and cellular abnormalities in cell models
and in tissue, and evaluating drug responses and the effectiveness
of therapeutic intervention strategies. Biomarkers are essential
tools in terms of basic research and clinical practices and they have
the ability to detect variations and/or states of a protein related to a
normal or abnormal cellular pathway. In other words, biomarkers
act as good indicators of normal biological process, pathogenic
processes and/or pharmacological responses to therapeutic in-
terventions (Mayeux, 2004; Tanha et al., 2016). Indeed, biomarkers
can be used to track and evaluate cell developmental stages and
differentiation processes. To further highlight this the FDA is pro-
moting biomarker discovery for basic and clinical researches
(Strimbu and Tavel, 2010).
This review aims to provide a comprehensive view of ectoderm
differentiation and how this inﬂuences cell stages. From stem cells
in the ectoderm layer to progenitors of each tissue, speciﬁc proteins
are differentially expressed affecting different biochemical and
cellular pathways. These proteins have numerous interactions and
intersections and only through a greater understanding of these
complex networks can we start to reap the beneﬁt towards areas
such as regenerative medicine.2. Neural crest
As the neural folds promote and join cells at the lateral edge or
Fig. 1. Zygote develops three germinal layers through gastrulation. Ectodermal derivatives speciﬁcally portrayed to provide a schematic overview of divers tissues thrived from
Ectoderm layer.
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The neural crest, then, experiences an epithelial-to-mesenchymal
transition, delaminating from the neuroepithelium and migrating
through the periphery to enter the basal mesoderm (Disc et al.,
2012). The neural crest constitutes four different populations
based on their migration pathway and unique cell types. The cranial
neural crest appears within the anterior part of the embryo and
develops cartilage and bone of the head, melanocytes, sensory
ganglia, and parasympathetic ganglia. The cardiac neural crest,
which represents a subdivision of the cranial neural crest, develops
aorticopulmonary septum, conotruncal cushions, and aortic arch
smooth muscle. The vagal neural crest gives rise to the enteric
nervous system (ENS). Finally, the trunk neural crest develops the
peripheral nervous system and skin melanocytes (Crane and
Trainor, 2006).Neural crest cells can differentiate into a variety of cell types but
the pluripotent potential of neural crest is still a matter of contro-
versy. It has been argued that although each cell is pluripotent they
may indeed be committed at the outset of migration or shortly
thereafter (Crane and Trainor, 2006). What is making this debate
challenging is the fact that human neural crest cells (hNCCs) ex-
press pluripotency markers such as homeobox protein NANOG
(NANOG), POU domain, class 5, transcription factor 1 (POU5F1) and
transcription factor SOX-2 (SOX2). Some endodermal markers, like
hepatocyte nuclear factor 3-beta (FOXA2), glypican-1 (GPC1),
transmembrane 4 superfamily member 2 (TM4SF2), C-X-C che-
mokine receptor type 4 (CXCR4) have also been detected in vitro in
hNCCs, which emphasizes the potential of neural crest cells to give
rise to extra non-physiologic progeny (Thomas et al., 2008). Mouse
cardiac neural crest cells comprise some pluripotent cells that can
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connective tissues, and sensory neurons whereas some of these
cells differentiate into limited cell types such as smooth muscle
cells, chondrocytes, and Schwann cells and some progenitors give
rise to smooth muscle cells or just melanocytes. This observation
proposes that there are pluripotent stem cells as well as multi-
potent and unipotent cells among cardiac neural crest cells, which
is shown in Fig. 2. Only 1e3% of neural crest cells are pure plurip-
otent stem cells yet a wide spectrum of neural crest populations are
multipotent or unipotent (progenitors) which can also be found in
adult some organs such as heart, hair follicles, gut and peripheral
nerves (Crane and Trainor, 2006).2.1. Peripheral nervous system
The peripheral nervous system (PNS) provides a connection
between external stimuli and internal responses. Sensory neurons
transfer signals from stimulus receptors to the central nervous
system andmotor neurons return the signal to organs, muscles, and
glands. Motor neurons are subdivided into the somatic nervous
system and the autonomic nervous system. The somatic nervous
system is responsible for voluntary control of movement and
transmits signals from the brain to the muscles. Conversely, the
autonomic nervous system transmits signals to smooth muscle and
glands and contribute to the sympathetic and parasympathetic
nervous system. The sympathetic nervous system represents the
“ﬁght or ﬂight” response whilst the parasympathetic system de-
velops the “rest or digest” system. Generally, PNS includes neurons,
Schwann cells, and satellite glial cells (SGCs). Each of these cells is
recognized by speciﬁc protein markers that can also deﬁne their
function (Janig and Habler, 2000).
Neural crest cells are committed to differentiate towards sen-
sory or autonomic lineages and environmental and transcriptional
factors determine their fates toward neurogenesis or glial genesis.
Alpha motor neurons (a-MNs) are motor neurons that supply
skeletal muscle (the extrafusal muscle ﬁbers) with nerves. a-MNs
are located within the gray matter that forms the ventral horn of
spinal cord while their axons travel down to muscles ﬁbers to send
motor signals via neuromuscular junction which launch muscle
contractions. They receive signals from a-MNs that can simulta-
neously innervate multiple muscle ﬁbers. Small muscles areFig. 2. Neural crest pluripotency patterns as insupplied by low innervation ratio whereas large muscles need
higher ratios of innervations of a-MNs that provide more precise
control by the CNS (Bear, F Mark. Connors,W Barry. Paradiso, 2007).
Containing smaller axons, the gamma motor neurons (g-MNs)
represent another type of lower neurons, residing in the same place
of a-MNs though providing a lower rate of velocity. They receive
input from themotor cortex and brainstem and innervate intrafusal
muscle ﬁbers. Their function is not associated with muscle
contraction but rather they contribute to the contraction of muscle
spindles, sensory receptors located within muscles that allow
communication to the spinal cord and brain. A signiﬁcant role of g-
MNs is to maintain the tautness of muscle spindles allowing the
continued ﬁring of alpha neurons, leading to muscle contraction
(Frebreg, 2009).
It is important to differentiate between fast motor neurons,
involved in fast and energy demandingmovements such as running
and leaping, and slowmotor neurons that coordinate smaller action
potentials for continued resistance to fatigue in actions such as
walking or standing (Ritzmann and Zill, 2009).
In terms of protein biomarker, POU domain, class 4, transcrip-
tion factor 1(Brn-3.0) and POU- domain transcription factors are
found in sensory neurons (Crane and Trainor, 2006). Although
neuronal nuclei (NeuN) antigen shows low expression levels in g-
MNs, Estrogen Related Receptor gamma (Err3) and GDNF family
receptor alpha-1 (Gfra1) are highly expressed. Osteopontin (OPN)
and NeuN remarkably deﬁne a-MNs. As shown by Misawa and co-
workers, OPN is responsible for neuronal maturation and estab-
lishment of long axons with a high rate of conduction velocity.
Similarly, it has been demonstrated that Chondrolectin (Chodl)
represents a fast motor neuron marker whilst synaptic vesicle
glycoprotein 2A (SV2A) is a known marker of slow motor neurons
(Misawa et al., 2012). SGCs that envelope nerve cell bodies in the
sensory, sympathetic and parasympathetic ganglia and are further
deﬁned by protein markers such as glutamine synthase (GS) and
S100 (Hanani, 2005). GS is the best marker for identifying SGCs
whilst S100 is not a speciﬁc marker of these cells because sub-
population of sensory neurons and Schwann cells also express this
protein. SGCs can also be detected by glial ﬁbrillary acidic protein
(GFAP) after axonal injury (Hanani, 2005).
Schwann cell markers differ due to the myelination state. Non-
myelinated Schwann cells can be detected by 217c (Ran-1), A5E3,vestigated by in vitro and in vivo analysis.
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myelin sheet causes down regulation of these proteins. Myelinated
Schwann cells express P0, myelin-associated glycoprotein (MAG),
myelin basic protein (MBP) as (Jessen et al., 1990) whilst the paired
box protein Pax-6 (AN2) protein is expressed by immature non-
myelinated Schwann cell at the embryo stage. Although AN2
expression is needed at the initiation of myelination, recent in-
vestigations revealed that AN2 expression is down regulated at the
late stages of myelination when the cells upregulate myelin genes
(Schneider et al., 2001). AN2 expression is very low in chemically
deﬁned cultures, which suggest that AN2 expression needs axonal
interaction as well as neural growth factors. After nerve damage,
AN2 expression does not show any change due to non-speciﬁc
expression in the ﬁbroblasts (Schneider et al., 2001). Conversely,
S100, neurotrophin receptor 75 (p75NTR) and E3 SUMO-protein
ligase EGR2 (Krox20) are not expressed in the early stages but
expressed in mature non-myelinated and myelinated Schwann
cells. It is interesting to note that the expression levels of Sox2 and
Sox10 are the same at every cell stage limiting their use neural stage
protein markers. Other suitable markers for Schwann cells include
POU domain, class 3, transcription factor 1 (Oct6), which is
expressed in more than 80% of Schwann cells, and NCAM that is
highly expressed by Schwann cells. In contrast, the GAP43 protein is
not expressed in mature myelin-forming Schwann cells but shows
basal expression in immature and non-myelinated Schwann cells
suggesting its potential as a protein marker. MPZ and BMP are
expressed in all developmental phases of Schwann cells but the
expression levels increase during differentiation (Z. Liu et al.,
2015b).
Sensory and motor Schwann cells have rather different
expression characteristics. In the sensory Schwann cells MBP,
NLGN1, brain-derived neurotrophic factor (BDNF) and glial cell
line-derived neurotrophic factors (GDNF) are signiﬁcantly
expressed, whilst in the motor Schwann cells protein kinase C iota
type (PRKCi), negative elongation factor E (NELF), vascular endo-
thelial growth factor (VEGF) and pleiotrophin (PTN) are highly
expressed and are considered as reliable protein markers (Jesuraj
et al., 2013). Among the above-mentioned proteins, PRKCi and
NEFL are involved in motor Schwann cells signaling and myelina-
tionwhilst NEFL participates in the microtubule assembly and axon
support. Speciﬁcally, PRKCi provides axonal support, intercellular
signaling, microtubule dynamics and cell survival (Jesuraj et al.,
2013). PTN also plays key roles in neural differentiation, migra-
tion, and proliferation where PTN expression is down-regulated
due to lack of axonal signaling. Indeed these factors should be
considered in the context of deﬁning proteinmarkers in cell culture
as important environmental cues may be absent in cell culture
(Jesuraj et al., 2013).
2.2. Dorsal root ganglion
The dorsal root ganglion (DRG) refers to the collection of cell
bodies of pseudounipolar sensory neurons, which send signals
from the periphery to the CNS. Ran-1 and S100 are expressed by
Schwann cells of the dorsal root ganglion. Similarly, ﬁbroblasts are
detected by Thy-1membrane glycoprotein (Thy-1) and ﬁbronectin-
1 (LETS) and Neurons of DRG are double positive for Tetanus
binding protein and Thy-1. It is worth mentioning that Tetanus
binding protein is an essential component of Tetanus toxicity
(driven from Clostridium tetani) aiding the binding to neurons
(Fields et al., 1978).
2.3. Enteric nervous system
The gastrointestinal tract contains its own nervous system,which is called the ENS and is often considered “the second brain”.
Although it works in harmony with the CNS, it can also operate
independently. It consists of two major plexuses which supply the
entire gastrointestinal tract: the myenteric plexuses settled be-
tween the inner and outer layer of the muscular external and
submucosal plexuses placed at submucosa (Nezami and Srinivasan,
2010).
The myenteric plexuses form a linear cluster of neurons whose
stimulation leads to increased tone, velocity, and intensity of in-
teractions in the gut. The submucosal plexuses provide local
secretion, absorption, and muscle movement. Different sets of
protein markers describe the type of neurons and glial cells of the
ENS. The neuromodulin (GAP43) and embryonic lethal, abnormal
vision, Drosophila-like protein2/4 (Elavl2/4) protein markers deﬁne
early differentiation of neurons whereas the same stage is deter-
mined by fatty acid-binding protein (Fabp7) for glial cells (Heanue
and Pachnis, 2006). Furthermore, early migration and axon exten-
sion are illustrated by the high expression levels of collapsin
responsemediator protein 1 (Crmp1), dihydropyrimidinase-related
protein 3 (Dpysl3) and neuropilin-1 (Nrp1). When neurons
approach the end of differentiation, they can be detected by VIP and
cocaine- and amphetamine-regulated transcript protein (CART). In
the postnatal ENS ganglia, the speciﬁc expression of ﬁbroblast
growth factor receptor 2 (FGFR2) has been clearly documented and
it is noteworthy that stathmin2/3 (Stmn2/3) and neuronal migra-
tion protein doublecortin (Dcx) are markers of axonal outgrowth
and S100b as a glial cell marker (Heanue and Pachnis, 2006)Similar
to other parts of the neural system, Sox2 is known as a neural
progenitor marker for the ENS. Other markers for ENS include Sty11
and synaptosomal-associated protein 25 (Snap25) (markers of
synaptogenesis) Hu and Gap43 (Pan-neuronal markers). Moreover,
the expression of proto-oncogene tyrosine-protein kinase receptor
Ret (Ret), mitogen-activated protein kinase10 (MAPK10) and Stmn2
are correlated with axonal rearrangement and neuronal out-
growth (Heanue and Pachnis, 2006). More recently novel protein
markers, such as ensconsin (ENS), distal-less homeobox protein
(Dlx1), ETS variant 1 (Etv1) and T-box transcription factor (TBX1)
Tbx3 have been investigated and suggested to represent new pro-
tein markers for ENS development (Heanue and Pachnis, 2006).
2.4. Adrenal medulla lineage
The adrenal medulla represents the central part of adrenal
glands covered by the adrenal cortex. It contains shapeless cells
surrounded by blood vessels and links to the sympathetic part of
the autonomic nervous system, generally called the sympathoa-
drenal (SA) system. It includes three types of cells: Chromafﬁn cells,
neurons, and small intense ﬂuorescence cells (SIF cells); each
characterized by speciﬁc markers. Being stimulated by pregangli-
onic nerves through secretion of acetylcholine, Chromafﬁn cells
secret norepinephrine and mostly epinephrine to blood vessels to
induce ﬁght or ﬂight response in the body (McCorry, 2007). Neu-
roﬁlament (NF) and tetrasialogangliosid A2B5 are expressed in SA
progenitors. Down-regulation of these markers are observed at
later stages in non-neural cells (like chromafﬁn cells) and they
maintain its expression in neurons. Peripherin is also highly
expressed in the neurons of SA. Tetanus binding protein is also
detected in chromafﬁn cells (Huber, 2006). Nitric oxide synthase
(NOS) is signiﬁcantly expressed in SIF cells. The tyrosine hydroxy-
lase (TH), dopamine beta-hydroxylase (DBH), nucleotide sugar
epimerase (NSE), PGP9.5, NCAM and chromogranin-A (CGA) pro-
teins are major markers of SIF cells. These markers, as well as
phenylethanolamine N-methyltransferase (PNMT), SNAP -25 and
GC receptors, veriﬁed as chromafﬁn cell markers (Huber, 2006).
SA1-5 antibodies are speciﬁcally marking chromafﬁn cells.
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expression pattern of these antigens maintains in the chromafﬁn
cells. These antigens ﬁrstly appear in the cytoplasm and gradually
move to the cell membrane during the developing process. It is also
noteworthy that Catecholamines are non-speciﬁc markers of SA
progenitors (Patterson, 1991). Similarly, TH, DBH, NF, NSE, PGP9.5,
B2, GAP-43, NCAM, neural cell adhesion molecule L1 (L1), CGA,
neuropeptide Y (NPY) and acetylcholinesterase (Ach) are key
markers of SA neurons (Huber, 2006).
2.5. Carotid bodies
Carotid bodies are a set of chemosensitive cells in the fork of
carotid arteries. Carotid body cells are divided into three types of
cells namely glomus cells (type1 and 2), sustentacular cells and
nerve endings. Glomus cells have special chemoreceptors which
are sensitive to oxygen and carbon dioxide pressure in the arterial
blood ﬂow and also to the pH and temperature (Kumar and
Prabhakar, 2012). Glomus cells and sympathetic neurons are
detectable by Tuj1, PGP9.5, TH, and NPY. Furthermore, no glomus
cells are dependent on achaete-scute homolog 1 (Mash1) because
superior cervical ganglion requires Mash1 function to stimulate the
neural progenitors to differentiate into glomus cell subtype
(Kameda, 2005). In contrast, retinal cells develop glial cells which
do not require Mash1. In mutant cells, GFAP and S100 reactive cells
appear which represent sustentacular cells, formed from ectome-
senchymal cells and, like sensory neurons, are generated inde-
pendently of Mash1expression (Kameda, 2005).
2.6. Melanocyte
Melanocytes are pigmented, neural crest-derived cells in the
skin, hair follicles, mucosa, cochlea (ear), iris (eye) and mesen-
cephalon (brain). Melanogenesis establishes strong protection
against ultraviolet radiation (Yamaguchi and Hearing, 2014). The L-
dopachrome tautomerase (TRP2/DT) protein is the initiatory
marker that determines neural crest offspring to form the mela-
noblast cell lineage (10dpc) in mouse (Steel et al., 1992). Dopa-pre-
melanin reactive melanoblast is detected from 14.5 dpc (Steel et al.,
1992). Melanocyte antigens M2 and M3 are primary markers of
melanocyte differentiationwhile no pigmentation has yet occurred
and epithelial morphology is observable. In humans, these markers
are also detectable in some subsets of melanomas. The M4, M5, and
M6 antigens are intermediate markers of melanocyte differentia-
tion (Houghton, Alan N. Eisinger, Magdalena. Albino, Anthony P.
Cairncross, J Gregory. Old, 1982). Spindle morphology and light
pigmentation are detected, occurring in fetal and newborn mela-
nocytes. Furthermore, the M9 and M10 proteins are late markers of
melanocyte differentiation which correspond to dendritic
morphology and full pigmentation and these types of melanocytes
are characterized as adult melanocytes. Albeit low levels of tyros-
inase expression in early and intermediate levels of differentiation,
late level of development is characterized by the high expression of
tyrosinase (Houghton, Alan N. Eisinger, Magdalena. Albino,
Anthony P. Cairncross, J Gregory. Old, 1982).
2.7. Meninges
Meninges are the three membranes that envelope the brain and
spinal cord protecting the CNS. The membranes include the pia
mater, the arachnoid mater and the dura mater (Decimo et al.,
2012). The Pia mater is a thin, ﬁbrous layer perforated by blood
vessels that feed the brain. The Pia mater is ﬁrmly attached to the
brain and spinal cord. The nomenclature of the arachnoid mater is
due to its net-like structure formed from ﬁbrous tissue.Cerebrospinal ﬂuid is localized under the arachnoid mater and
covers the pia mater. The dura mater is the outmost layer of
meninges with a dense structure without extracellular spaces. It
covers dural sinuses which collect and drive the blood from brain to
heart. Interestingly, themeningesmembranes are not limited to the
space surrounded by the CNS and covering bones but it also pen-
etrates into neuronal tissue suggesting that the meninges have
additional physiological roles beside protection (Decimo et al.,
2012). Meninges contain three joints including the blood-CSF bar-
rier through arachnoid mater, the blood-CSF barrier in pial micro-
vessels, and the utmost the CSF-brain barrier that includes the glial
end feet layer (Brøchner et al., 2015). One main protein marker for
the meninges is the Dcx protein that is highly expressed
throughout this structure. There is also considerable evidence that
excitatory amino acid transporter 1 (EAAT1), IL-13Ra2, brain-lipid
binding protein (BLBP) can be used as markers of the glial end-
feet layer. Leptomeningeal cells and the end feet glial cell layer are
also marked with stage-speciﬁc embryonic antigen-4 (SSEA-4) and
chitinase 3 like 1 (YKL-40) (Brøchner et al., 2015). Indeed, the YKL-
40 protein is strongly expressed at the pia-arachnoid tissue whilst
the collagen-1 protein is expressed speciﬁcally in the pia mater and
moreover, the claudin-11 and connexin 43 (Cx43) are speciﬁcally
located in the arachnoid mater (Bifari et al., 2015). Moreover, it is
noteworthy that the leptomeningeal cells contain a subset of cells
with neural progenitor markers including Sox2, nestin, and
vimentin. This knowledge suggests that meninges are the host of
neural progenitor cells during both embryonic development and
adulthood. Similarly, high expression of growth factors like
epidermal growth factor receptor (EGFR), ﬁbroblast growth factor
receptor1 (FGFR1) and homing chemotactic agents such as SDF-1 in
the leptomeninges section indicates the cellular dynamic state of
the CNS (Bifari et al., 2015).
2.8. Dental pulp
The pulp is a connective tissue consisting of odontoblasts which
contain blood vessels and nerve ﬁbers. A large proportion of pulp is
placed within pulp chambers (central cavity of the tooth) and
trauma and infection represent major drives for the dental pulp
stem cells (DPSCs) to regenerate pulp tissue, e.g. odontoblasts.
Recent studies have shown the presence of differentiation protein
markers including bone gamma-carboxyglutamate protein (OCN),
dentin sialophosphoprotein (DSPP), alkaline phosphatase (ALP) and
matrix extracellular phosphoglycoprotein (MEPE) in DPSCs(Wei
et al., 2007). Stromal cell surface marker-1 (STRO-1) and CD146
also represent dental pulp cell markers (Wei et al., 2007) and
interestingly CD51/CD140a acts as a speciﬁc marker for dental stem
cells which can generate both odontoblasts and chondroblasts
(Alvarez et al., 2015). Another protein marker, CD271, probably
represents the most suitable markers to isolate dental mesen-
chymal stem cells (Alvarez et al., 2015). Due to the beneﬁcial
characteristics of DPSCs and the promising ﬁndings on the use of
these cells in cell therapy, the identiﬁcation of protein markers for
these cells is gaining traction. One interesting ﬁnding is that the
in vitro enrichment of TNF-a boosts the stem cell-like features of
dental pulp cells and increases the expression of stem cell markers
such as SSEA-4, CD146, STRO-1, OCT-4, and NANOG (Ueda et al.,
2014).
2.9. Parathyroid glands
Four small parathyroid glands are located behind the thyroid
gland in the neck. In spite of their anatomical connection, para-
thyroid glands have no physiological connection to the thyroid
gland. The primary lateral components are developed from the
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median part originates from the third and fourth pharyngeal
pouches of the endoderm (Molina, 2010). Parathyroid glands pro-
duce the parathyroid hormone (PTH) that helps regulate calcium
levels in the blood (within the range of 8.5e10.5mg/dl). Calcium is
a crucial element of muscle contractions and signal conduction in
neurons and an imbalance of calcium levels may lead to neuronal or
muscular damage. PTH ensures calcium and phosphate hemostasis
in the body within blood and bones. When the circulating calcium
level is a too low large amount of PTH is released to blood vessels
targeting bones, gastrointestinal tract, and kidneys to respectively
release and preserve calcium. The opposite effect of PTH on phos-
phate levels is mediated through the targeting of the proximal
tubule of kidney nephrons to ﬁnally decrease phosphate levels in
the blood when calcium levels are going to increase. Parathyroid
glands contain two types of cells: Chief cells and Oxyphil cells. Chief
cells are the major cells found in large number with round nuclei
and they are responsible for the synthesis of PTH whereas Oxyphil
cells are lesser in number and have a smaller nucleus with eosin-
ophilic cytoplasm. They appear at the commencement of puberty
and no function has yet been declared for these cells (Molina, 2010).
Collectively, the above data suggest that PTH is a robust marker for
chief cells. Additionally, the calcium-sensing receptor (CaSR), which
detects calcium blood levels, represents yet another protein marker
of Chief cells. Glial cells missing 2 (GCM2) protein is a transcription
factor responsible for the development of the parathyroid gland
from pharyngeal pouches (Gonzalez Campos, 2014). GCM2 loss-of-
function mutations cause hyperthyroidism with the absolute
absence of PTH. Both PTH and GCM2 are present in the Oxyphil cells
making them suitable protein markers for these cells (Gonzalez
Campos, 2014). The CGA is a secretory protein from the Granin
family which is involved in parathyroid hormone secretion. This
protein can bind to calcium and form bulks of calcium supply and
also regulate PTH release (Gonzalez Campos, 2014). The CGA pro-
tein is the main granin expressed in Chief cells and thus is
considered as a good protein marker for these cells. Moreover,
various studies have shown that the C-C motif chemokine
21(CCL21) protein is a speciﬁc marker of parathyroid development
(Bingham et al., 2009). Similarly, studies on adenoma primary
cultures have revealed the expression of steroid-related markers,
such as mineralocorticoid Receptor (MR), Glucocorticoid receptor
(GR), and corticosteroid 11-beta-dehydrogenase isozyme 2
(11bHSD2) in these cells suggesting a possible presumptive effect of
hyperparathyroidism to induce hyperaldosteronism (Gonzalez
Campos, 2014).
3. Neural tube
The neural tube is the embryonic structure which develops the
CNS. Formation of the neural tube occurs through two processes:
primary neurulation and secondary neurulation. Primary neurula-
tion starts when the cells in the border of the neural plate migrate
toward the midline and fusing in the center of the neural fold.
Secondary neurulation cast a hollowneural tube in the center of the
neural plate. The neural tube ultimately forms the brain (Prosen-
cephalon, Mesencephalon, and Rhombencephalon) and the spinal
cord.
3.1. Central nervous system
The central nervous system comprises the brain and spinal cord.
The brain is protected by the osseous skull and the spinal cord by
the spinal canal. The brain is divided into three major parts
including the forebrain, midbrain, and hindbrain. The forebrain
controls speech, thoughts, perception, and processes sensoryinputs and provides motor functions. The midbrain, in concert with
the hindbrain, constructs the brain stem. In effect, the midbrain
represents the part that connects the forebrain to the hindbrain.
Lastly, the hindbrain extends from the spinal cord and includes
pons and cerebellum which ensures movement harmony, balance,
and guidance of sensory signals (Matter et al., 1991).
The spinal cord is a long cord that stretches out from the neck to
the lower back. It is a bundle of nerve ﬁbers that launch sensory
signals (ascending or afferent inputs) from the periphery to the
brain and transmits motor instructions (descending or efferent
inputs) from the brain to the periphery. The spinal cord solely co-
ordinates muscle responses in response to exterior impulses.
The CNS comprises neurons and different subtypes of glial cells.
Glial cells provide neuronal protection, regulates signal trans-
duction, synapse conduction and repair processes after injury
(Purves D, Augustine GJ, Fitzpatrick D, 2001). Classiﬁed by size, they
are divided into two groups: the microglia and the macroglia. The
microglia consists of macrophages that act as the immune system
agents in the CNS. They are mobile and they monitor brain in-
fections and injuries. However, the macroglia is subdivided into
astrocytes, oligodendrocytes, ependymal cells, and radial glial cells.
Astrocytes act as mediator cells between neurons and blood
vessels. They mediate delicate connections to blood vessels in order
to nourish neuronal cells and to establish the blood-brain barrier.
They control the ECM in relation to ion and neurotransmitter
concentrations. Astrocytes react to any slight CNS inﬂammation
which produces a pathological state called astrogliosis. Astrogliosis
mediates many clinical complications of CNS disorders (Purves D,
Augustine GJ, Fitzpatrick D, 2001) and they are reactive to GFAP
and GS (Anlauf and Derouiche, 2013).
Oligodendrocytes are the Schwann cells counterparts in the
CNS. They produce myelin sheath around surrounding axons. One
interesting difference is that oligodendrocytes support myelination
of several axons whilst Schwann cells surround only one axon. At
the onset of oligodendrocyte differentiation, the gut tumor sup-
pressor gene adenomatous polyposis coli (Apc) is the ﬁrst marker
observed and reticulon-4 (Nogo-A) and MBP are observed as
mature oligodendrocyte protein markers (Fancy et al., 2014). In
addition, MAG, MOG, oligodendrocyte-myelin glycoprotein
(OMgp), and 20,30-cyclic nucleotide 30 phosphodiesterase (CNPase)
act as appropriate markers for mature oligodendrocytes (Miron
et al., 2011).
Ependymal cells are epithelial shaped cells that cover the ven-
tricles of the brain, the central canal of the spinal cord and the
choroid plexus. They possess speciﬁc structures called cilia which
regulate CSF ﬂow to produce a homogeneous matrix that supplies
neurons with nutrients and remove unwanted metabolites. The
ependymal cells are characterized by the expression of activating
transcription factor 3 (ATF3) which is initially detectable in the
cytoplasm of ependymal spinal stem cells although at a later time
point located in the nucleus of activated cells (Mladinic et al., 2014).
Radial glial cells are bipolar shaped multifunctional cells which
develop from neuroepithelium of the CNS during fetal develop-
ment (Rakic, 2009). Some populations of radial glial cells remain
functioning in the adult brain in the neurogenic niches. They lodge
in the cerebral cortex in the ventricle zone. Apart from playing as a
constructive element for neuronal routing, they are also known as
precursors that develop neurons, astrocytes, and oligodendrocytes
(Barry et al., 2014). During the migration, BLBP, neuregulin, and
astrotactin have potential functions in neuronal guidance
(Parnavelas and Nadarajah, 2001). Moreover, radial glial cells are
reactive to granulocyte colony-stimulating factor receptor (G-CSFR)
in prenatal murine brain development (Kirsch et al., 2008).
Through radial glial cell differentiation to astrocyte cells, they
gradually abolish the expression of nestin (RC2, RAT401), and
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Nadarajah, 2001). Various studies indicate that astrocyte-speciﬁc
glutamate transporter (GLAST), BLBP, and vimentin are radial glial
cell protein markers. A recent investigation demonstrated that
BLBP may trigger neuronal fate of radial glial cells and GLAST drives
radial glial cells toward gliogenesis (Howard et al., 2008). This in-
formation suggests the multipotent capacity of radial glial cells and
their importance in regenerative medicine studies.
Beside speciﬁc marker proteins that deﬁne cell type in the CNS,
different regions of the CNS have speciﬁc expression patterns
aligned to their function. For example, the substantia nigra is
located in themidbrain and is a basal ganglia structure consisting of
dopaminergic neurons (DA) (Jami et al., 2015; M. Jami et al., 2014b).
It is known that Folate receptor alpha (FolR1) is a marker of
dopaminergic neuronal progenitors in the midbrain and CD166
antigen (Alcam), SUN domain-containing ossiﬁcation factor (Ch1),
immunoglobulin superfamily member 8 (Igsf8), and GDNF family
receptor alpha (GFra) represent markers for DA. Similarly, the
bonaﬁde midbrain dopaminergic lineage marker LIM homeobox
transcription factor 1-alpha (Lmx1a) is expressed during prenatal
murine development (Gennet et al., 2016). Other examples include
fer3-like protein (Nato3) and Hes family bHLH transcription factor
1 (Hes1) (in ﬂoor plate), orthodenticle homeobox 2 (Otx2) (in
forebrain and midbrain), gastrulation brain homeobox 2 (Gbx2) (in
posterior and anterior rhombencephalon), nuclear receptor sub-
family 4 group A member 2 (Nurr1) and pituitary homeobox 3
(Pitx3) (in ventral midbrain with a suggested role in ventral
midbrain (VM) dopaminergic neuronal survival) and engrailed
homeobox 1/2 (En1/2) (in the border of midbrain-hindbrain). One
protein markers of the development of the telencephalon are
EphrinA5 (Hegarty et al., 2013). Furthermore, high expression of
paired box protein Pax-6 (Pax6) has been demonstrated in the
dorsal parts of the telencephalonwhereas GS homeobox 2 (Gsh2) is
a protein marker of the middle part of the telencephalon and the
central region of the telencephalon is speciﬁed by the high
expression of NK2 homeobox (Nkx2) and oligodendrocyte tran-
scription factor 2 (Olig2) (Rallu et al., 2002).
4. Surface ectoderm
The surface ectoderm generally develops skin, cornea, and tooth
enamel. The major signaling pathways regulating lineage
commitment of surface ectoderm are BMP, Wnt/b-catenin,
Hedgehog, and Fgf (Qu et al., 2016). Herewe discuss the biomarkers
of the largest derivative of surface ectoderm, skin. Skin is composed
of four different cell types including Keratinocytes, Merkel cells,
Melanocytes, and Langerhans cells.
Keratinocytes are the dominant cells type in the epidermis. P63
is the transcription factor that preserves keratinocytes precursors
and involucrin is essential in the terminal differentiation of kera-
tinocytes (Green et al., 2003). One of the well-studied epidermal
proteins is Keratin 19 which has been suggested as a good protein
marker of human epidermal stem cells in the hair follicle bulge and
the outer root sheath of hair. High expression of b1 integrin and its
rapid attachment to collagen IV and ﬁbronectin leads to a popula-
tion of epidermal stem cells. A recent investigation revealed a
method for isolating a population of cells containing both
epidermal stem cells and transient amplifying cells (Watt, 1998).
Despite low expression of b1 integrin and the slow attachment to
the extracellular matrix (ECM), the use of antibodies reactive to b1
integrin, E-cadherin, b-catenin, and plakoglobin have proven to be
successful in isolating relatively pure populations of epidermal
stem cells (Watt, 1998). However, more recent ﬁndings have
demonstrated that a6 integrin is more suitable for detecting
epidermal stem cells and by using a combination of b1integrin anda6 integrin it may be possible to increase the purity of epidermal
stem cells (Lavker and Sun, 2000). It is also noteworthy that other
studies have introduced lectin as a suitable marker for mature
keratinocytes (Reano et al., 1982). Expression of involucrin and the
keratins genes are regulated by keratinocyte differentiation and
multiple external stimuli such as calcium and vitamin A (Eckert and
Rorket, 1989).
Merkel cells are post-mitotic neuroendocrine cutaneous cells
primarily localized within the compact epidermal sensory network
in the epidermal bulge. There is a great site variation in the density
of Merkel cells. Merkel cells are distinguished with different pu-
tative markers of cutaneous cell type of which Cytokeratin 20 is
known for the highest rate of selectivity (Polakovicova, 2011).
5. Ear
The ear anatomy is made of three distinctive structures known
as the external ear (pinna and ear canal), the middle ear (tympanic
membrane and ossicles), and the inner ear (semicircular canals,
vestibule, and cochlea). The pinna directs sound to tympanic
membrane and vibration of the tympanic membrane is transmitted
to the cochlea via ossicles. In cochlea movements of ﬂuids is con-
verted to neural signals by specialized cells known as hair cells. Hair
cells are capped with stereocilia in which the dynamics of the
stereocilia is exchanged to neural signals and transmitted to the
auditory cortex in the temporal lobe (Anbuhl et al., 2016; Graven
and Browne, 2008).
5.1. Inner ear
The inner ear emerges from a non-neural ectoderm region
named as otic placode adjacent to the caudal part of the hindbrain.
The otic placode is one of the ectodermal thickenings arisen around
the edge of the anterior neural plate (Whitﬁeld, 2015). It is further
developed to Cochlea (allocated to hearing) and Vestibular System
(specialized for balance) (Torres and Giraldez, 1998).
The otic placode is indeed the origin of most of the inner ear cell
types, including sensory neurons, sensory hair cells, supporting
cells and secretory cells (Whitﬁeld, 2015). Pax2-8, Eyes absent
homolog 1- homeobox protein six (Eya1-Six1), and Sox2 tran-
scription factors increase expression of Neurogenin1 (Neurog1) in
otic progenitor cells leading toward a primary auditory nerve
lineage (Gunewardene et al., 2014). Neurog1-expressed cells exfo-
liate from the otic vesicle to centrally create auditory nerve cells
and the vestibular ganglion neurons laterally which is signiﬁcantly
distinguished by Insulin gene enhancer protein ISL-1 (ISLET1)
(Gunewardene et al., 2014; Li et al., 2004). The exfoliated neurons
down regulate the expression of Neurog1. In this stage, they could
be discovered by expression of the neurogenin differentiation fac-
tor1 (Neuro D1), Brn3a, and transcription factor GATA3 during their
differentiation into sensory neurons. Thereafter, the mature audi-
tory neurons express the characteristics of pan-neuronal cyto-
skeletal markers NF, bIII tubulin, the vesicular glutamate
transporter (VGLUT1), the tyrosine receptor kinase B (Trk B), and C
(Trk C), BDNF, neurotrophin 3 (NT3), Calretinin, Tau, Neurog1,
glutamate receptor 4 (GluR4), and NeuroD (Gunewardene et al.,
2014; Peng et al., 2015).
Both cochlea and vestibular system consist of an intricate
apparatus (hair cells) to maintain hearing ability and balance. The
differentiation of hair cells begins from 10 to 12 weeks and pri-
marily starts with inner hair cells and lastly with outer hair cells
(Graven and Browne, 2008).
The inner hair cells recognized the auditory signal while outer
hair cells intensify the signals. The neural signal is then carried by
vestibulocochlear (VIII) cranial nerve to the brainstem (Bonito and
Fig. 3. Compartmentation of ectoderm derived tissues. Representative biomarkers for each tissue are included in parenthesis.
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The internal ear stem cells differentiate into pro-neural cells,
non-sensory cells, and pro-sensory cells. To develop pro-neural
cells from stem cells Sox2 and Neurog1 are necessary. Jagged1,
Notch1, SOX2, BMP-4, FGF, and IGF-1 are essential to creating pro-
sensory cells. Brn3c, Espin Barhl1, Myosin VI, VIIA, and XV are
required in the terminal differentiation, maintenance and survival
of hair cells (Liu et al., 2014). Brn3c is required for maturation and
survival of inner ear hair cells (Xiang et al., 1998). Prestin is the
prominent candidate of cochlear outer hair cells biomarkers. It is a
member of anion transporters that is expressed in the lateral
membrane of cochlear outer hair cells. It is responsible for elec-
tromotility of outer hair cells (Liberman et al., 2002). Lack of
functional Prestin in the knock out mice leads to sever hearing loss.
In vivo studies of lack of outer hair cells presented an upregulation
of Prestin in the remaining outer hair cells to retaliate the loss of
outer hair cells in the cochlea and reduced force production (Xia
et al., 2013). Beside upregulation in the cellular level, the amount
of Prestin release in the serum is also increased by cochlear damage.
Thus it is considered as an early indicator of cochlear trauma
(Dogan et al., 2018).
Myosin VII-A along with Espin, parvalbumin alpha 3, and
AchRa9 are characterized as differentiated protein biomarkers of
Hair cells (Li et al., 2003). Moreover, as recent studies of stem cell
differentiation into hair cells have reported parvalbumin alpha3,
Pou4f3 (Brn3c), unconventional myosin-XV (MyoXV), Espin (Q. Liu
et al., 2015a), Eya1-Six1, protein atonal homolog 1 (Atoh1), Sox2,
and MyoVIIA are of the most recognized markers of hair cells
(Ahmed et al., 2012; Mahmoudian-Sani et al., 2018). Atoh1, Jagged2,
and Delta1 direct the differentiation process toward hair cells (Liu
et al., 2014).
Other putative hair cells biomarkers are discovered by RNA-seq
data on in-vitro studies which are beyond the capacity of this
article to discuss (Taylor et al., 2018).
Inner and outer hair cells are separated from each other by
supporting cells. Supporting cells have the same origin as the hair
cells’ with physiological and morphological differences. These dif-
ferences are also observed between inner and outer hair cells. For
instance, inner hair cells are round and small but outer hair cells are
long and thin. Inner hair cells are arrayed in a single row and outer
hair cells are arrayed in three parallel rows. Furthermore, damage
to the inner hair cells causes sensory neural hearing loss (SNHL) but
any trauma to the outer hair cells will affect qualities of cochlear
signals to the brain (Devarajan et al., 2011). Surveys such as that
conducted by Li et al. have shown that inner and outer hair cells
transcriptome proﬁles are distinctively dissimilar. For example
Calb2, Calm1, Nhih1, Otof, are signiﬁcantly expressed in inner hair
cells by a much higher rate than outer hair cells. While Lmod3, Ptgir
and Ptprq are exclusively expressed in outer hair cells more than
inner hair cells (Li et al., 2018).
The mammalian auditory system has two main types of sup-
porting cells: the Deiter's cells support the outer hair cells at the
base, and the Pillar cells facilitate the formation of the reticular
lamina, which isolates the stereocilia from their cell bodies. A few
other supporting cells types include inner Phalangeal cells, Hen-
sen's cells, Claudius cells and Boettcher cells that are specialized
cells and are not associated with hair cells (White et al., 2006).
Supporting cells of the vestibular system have not yet fully un-
derstood (Matsui et al., 2005; Matsui and Ryals, 2005).
BETA2/Neurod1, Jagged2 are key regulators of supporting cell
fate (Wang et al., 2010; Zine et al., 2000). Cyclin-dependent kinase
(cdk) inhibitors (p27kip1, p19Ink4d, and Rb) and Notch Signaling
also interfere with hair cell differentiation and establishes sup-
porting cell fate in the differentiation process (Devarajan et al.,
2011; Liu et al., 2014). Both hair and supporting cells are derivedfrom pro-sensory progenitors. (Liu et al., 2014). Transcription fac-
tors Hes1-5 contributes to the development of supporting cells by
generation of supporting cells by ceasing Atoh1 expression. How-
ever, TGF-a promotes trans-differentiation of supporting cells into
hair cells (Liu et al., 2014).
Ectoderm layer is composed of different tissue with diversely
specialized biomarkers imprinting their territories. Not all tissues
are embedded in this review. An outline of tissue related bio-
markers is drawn in Fig. 3.
6. Conclusion
In this review we provided a detailed picture of biomarkers in
the normal form of neural tissues and some other ectodermal de-
rivatives to exclusively put the protein biomarkers on the map of
research and clinic. Biomarkers are in fact very good indicators of
biological and pathogenic processes and can be used to evaluate
ongoing molecular phenomena within the cells. In this regard, a
brighter overview on the protein biomarker expression proﬁle in
different neural tissues would deﬁnitely beneﬁt other studies
dealing with the pathogenic processes and/or pharmacological
responses to therapeutic interventions for clinical or diagnostic
purposes.
The formation of the neural crest, neural tube and surface
ectoderm provides early speciﬁc expression pattern of protein
markers in different parts of fetal tissues. As an example, protein
markers that characterize the PNS neuronal lineage include OPN,
SV2A, Chodl, just to mention a few. Furthermore, the ENS neuronal
cells become distinct by expression of Elavl2/4, Crmp1, Nrp1, and
Stmn2/3. Some non-neuronal lineages, such as melanocytes, are
distinguished by TRP2/DT, Dopa-pre-melanin, and tyrosine in
different developmental stages. Even different zones of the brain
are distinguishable by a series of distinct protein markers. For
example, the midbrain is identiﬁed by Alcam, Igsf8, Gfra expres-
sion. Moreover, the telencephalon is characterized by the expres-
sion of Gsh2, Nkx2, and Olig2. In order to gain a thorough
understanding of cell development (differentiation, regeneration,
and dedifferentiation) from zygote to specialized tissues there is a
need to further identify and characterize protein markers at each
stage of neural cell development and from this create a compre-
hensive protein network blueprint.
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